PEARL THERAPEUTICS INC

Profile

Company Names

PEARL THERAPEUTICS INC

Addresses

200 SAGINAW DRIVE, REDWOOD CITY, CA 94063

Phone Numbers

(650) 305-2600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$74,026,659.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-10-29 
$23,273,192.00 
$66,097,374.00 
$42,824,182.00 
Equity 
2
2012-06-12 
$13,300,133.00 
$14,317,189.00 
$1,017,056.00 
Debt 
1
2010-10-13 
$37,453,334.00 
$69,853,334.00 
$32,400,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
 
BRAMLAGE 
EXECUTIVE OFFICER, DIRECTOR
PEARL THERAPEUTICS INC   |  EIGER BIOPHARMACEUTICALS, INC.
SARVAJNA 
 
DWIVEDI 
EXECUTIVE OFFICER
PEARL THERAPEUTICS INC   |  REVIVA PHARMACEUTICALS, INC.
KEVIN 
 
FERRO 
DIRECTOR
PEARL THERAPEUTICS INC   |  ARISAPH PHARMACEUTICALS INC   |  IMMUSANT, INC.   |  MELINTA THERAPEUTICS, INC. /NEW/
MICHAEL 
 
GOLDEN 
EXECUTIVE OFFICER
PEARL THERAPEUTICS INC   |  NEWSBOUND, INC.   |  SWIRL NETWORKS, INC.
STEVEN 
 
JAHARIS 
DIRECTOR
PEARL THERAPEUTICS INC   |  ARISAPH PHARMACEUTICALS INC
SUNDAR 
 
KODIJALAM 
DIRECTOR
PEARL THERAPEUTICS INC
SUNDAR 
 
KODIYALAM 
DIRECTOR
PEARL THERAPEUTICS INC   |  IMMUSANT, INC.
THOMAS 
 
KOESTLER 
DIRECTOR
PEARL THERAPEUTICS INC   |  ARISAPH PHARMACEUTICALS INC   |  IMMUSANT, INC.
KATHY 
 
LAPORTE 
DIRECTOR
PEARL THERAPEUTICS INC   |  ELYSIUM THERAPEUTICS, INC.   |  D2G ONCOLOGY, INC.
JAMES 
 
NIEDEL 
DIRECTOR
TIOGA PHARMACEUTICALS INC   |  INTARCIA THERAPEUTICS, INC   |  CHIMERIX INC   |  PEARL THERAPEUTICS INC
CHADWICK 
 
OREVILLO 
EXECUTIVE OFFICER
PEARL THERAPEUTICS INC
WILLIAM 
 
PICHT, JR. 
EXECUTIVE OFFICER
PEARL THERAPEUTICS INC
COLIN 
 
REISNER 
EXECUTIVE OFFICER
PEARL THERAPEUTICS INC
HOWARD 
 
ROSEN 
EXECUTIVE OFFICER, DIRECTOR
CNS THERAPEUTICS INC   |  PEARL THERAPEUTICS INC   |  ALDEA PHARMACEUTICALS, INC.   |  INTACT VASCULAR, INC.   |  VESPER MEDICAL, INC.   |  ACELRX PHARMACEUTICALS INC   |  HOPEWELL THERAPEUTICS, INC.
HOWARD 
B. 
ROSEN 
DIRECTOR
PAXVAX INC   |  ACELRX PHARMACEUTICALS INC   |  PEARL THERAPEUTICS INC   |  KALA PHARMACEUTICALS, INC.   |  PAXVAX, INC.   |  KALA BIO, INC.
NICHOLAS 
 
SIMON 
DIRECTOR
PEARL THERAPEUTICS INC
NICHOLAS 
J. 
SIMON 
DIRECTOR
ACHILLION PHARMACEUTICALS INC   |  PEARL THERAPEUTICS INC   |  CLARUS LIFESCIENCES III, L.P.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  CLARUS IV-D, L.P.   |  CLARUS IV-C, L.P.   |  CLARUS IV-B, L.P.   |  CLARUS IV-A, L.P.
JAMES 
 
YOUNG 
DIRECTOR
TITLE CENTER OF INDIANA LLC   |  KING-ERNEST + WOODBINE DRILLNG PROGRAM I, L.P.   |  CLEARVIEW ENERGY, LP   |  PEARL THERAPEUTICS INC   |  3-V BIOSCIENCES, INC.   |  CLEARVIEW ENERGY II, L.P.   |  CLEARVIEW ENERGY III, L.P.   |  TARGETED MICROWAVE SOLUTIONS INC.   |  BREF 1900 LLC   |  FIRST BANK LUBBOCK BANCSHARES INC   |  FRESENIUS MEDICAL CARE SE FORT WORTH, LLC   |  COVETRUS, INC.   |  SABOT-ELMO, LLC   |  SABOT-LAKELINE, LLC   |  REDEEM- 1600 E. SANFORD LLC   |  SABOT ODESSA LLC   |  ADC.NT.2 VENTURE CAPITAL FUND, LLC   |  ADC.NT.1 VENTURE CAPITAL FUND, LLC   |  SAGIMET BIOSCIENCES INC.   |  ABRIDGED INC.   |  TRISALUS LIFE SCIENCES, INC.
JAMES 
W. 
YOUNG 
DIRECTOR
SUNESIS PHARMACEUTICALS INC   |  PEARL THERAPEUTICS INC   |  CHRONO THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-11-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-06-12 
2012-11-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-29 
2010-11-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#